139 related articles for article (PubMed ID: 10447952)
1. Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships.
Natale NR; Rogers ME; Staples R; Triggle DJ; Rutledge A
J Med Chem; 1999 Aug; 42(16):3087-93. PubMed ID: 10447952
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
[TBL] [Abstract][Full Text] [Related]
8. Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS.
Mohajeri A; Hemmateenejad B; Mehdipour A; Miri R
J Mol Graph Model; 2008 Apr; 26(7):1057-65. PubMed ID: 17959402
[TBL] [Abstract][Full Text] [Related]
9. 4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds.
Natale NR; Steiger SA
Future Med Chem; 2014 May; 6(8):923-43. PubMed ID: 24962283
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
Tunçbilek M; Ertan R
Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Miri R; Knaus EE
Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789
[TBL] [Abstract][Full Text] [Related]
12. Radioligand binding studies on some dihydropyridine analogues as probes of the dihydropyridine receptor.
Kettmann V; Drímal J; Svétlík J
Pharmazie; 1996 Oct; 51(10):747-50. PubMed ID: 8941943
[TBL] [Abstract][Full Text] [Related]
13. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.
Hemmateenejad B; Miri R; Akhond M; Shamsipur M
Arch Pharm (Weinheim); 2002 Dec; 335(10):472-80. PubMed ID: 12506395
[TBL] [Abstract][Full Text] [Related]
16. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
[TBL] [Abstract][Full Text] [Related]
17. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of nonpeptide mimetics of omega-conotoxin GVIA.
Baell JB; Duggan PJ; Forsyth SA; Lewis RJ; Lok YP; Schroeder CI
Bioorg Med Chem; 2004 Aug; 12(15):4025-37. PubMed ID: 15246080
[TBL] [Abstract][Full Text] [Related]
19. Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines.
Zamponi GW; Stotz SC; Staples RJ; Andro TM; Nelson JK; Hulubei V; Blumenfeld A; Natale NR
J Med Chem; 2003 Jan; 46(1):87-96. PubMed ID: 12502362
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial synthesis and screening of a chemical library of 1,4-dihydropyridine calcium channel blockers.
Gordeev MF; Patel DV; England BP; Jonnalagadda S; Combs JD; Gordon EM
Bioorg Med Chem; 1998 Jul; 6(7):883-9. PubMed ID: 9730224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
